335
Participants
Start Date
April 1, 2025
Primary Completion Date
May 31, 2026
Study Completion Date
June 30, 2028
Experimental
Participants will receive treatment with Abbott's Coronary IVL System followed by stenting.
RECRUITING
Montefiore Medical Center - Moses Division, The Bronx
RECRUITING
North Shore University Hospital, Manhasset
RECRUITING
St. Francis Hospital, Roslyn
RECRUITING
Pinnacle Health System, Mechanicsburg
RECRUITING
Sentara Norfolk General Hospital, Norfolk
RECRUITING
Piedmont Heart Institute, Atlanta
RECRUITING
UF Health Jacksonville, Jacksonville
RECRUITING
First Coast Cardiovascular Institute, Jacksonville
RECRUITING
The Cardiac & Vascular Institute Research Foundation, LLC, Gainesville
RECRUITING
AdventHealth Orlando, Orlando
RECRUITING
Mt. Sinai Medical Center, Miami Beach
RECRUITING
AdventHealth Tampa, Tampa
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Abbott Northwestern Hospital, Minneapolis
RECRUITING
Endeavor Health, Evanston
RECRUITING
Northwestern Memorial Hospital, Chicago
RECRUITING
Carle Foundation Hospital, Urbana
RECRUITING
Via Christi Regional Medical Center - St. Francis Campus, Wichita
RECRUITING
Bryan Heart, Lincoln
RECRUITING
Arkansas Heart Hospital, Little Rock
RECRUITING
Ascension St. John Jane Phillips, Bartlesville
RECRUITING
The Heart Hospital Baylor Plano, Plano
RECRUITING
Baylor Scott & White Heart & Vascular Hospital, Dallas
RECRUITING
Shannon Clinic, San Angelo
RECRUITING
HonorHealth, Scottsdale
RECRUITING
Brigham & Women's Hospital, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
Abbott Medical Devices
INDUSTRY